NSE filing, NSE: SURAKSHA. Summary written from the filing by ALFA Finder's alert engine.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹325.45
- Market cap
- ₹1,695 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 47.4×Sector 53.7×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Legal & Regulatory
Suraksha Diagnostic disclosed a one-day delay in shareholding pattern filing, leading to a Rs. 2,360 fine. The Board has noted remedial measures to prevent future recurrence.
Suraksha Diagnostic Management Change
Suraksha Diagnostic has appointed Ms. Shreya Arora as Company Secretary and Compliance Officer, effective October 14, 2026.
Suraksha Diagnostic Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting scheduled for September 22, 2026, to conduct routine business and dividend declaration.
- Value
- ₹0.01 Cr
Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Limited has issued a notice for its 21st Annual General Meeting to be held on September 22, 2026, to transact key corporate business.
Other board meeting date announcements
All →Pan Electronics India Board Meeting Date
PAN Electronics (India) intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 18 November 2026.
Mangalam Industrial Finance Board Meeting Date
Mangalam Industrial Finance scheduled a board meeting for November 6, 2026. It will consider unaudited Q2 and H1 FY27 standalone results.
Olympic Cards Board Meeting Date
Olympic Cards schedules a board meeting on 12 November 2026 to consider unaudited quarterly results. The trading window stays closed until results are declared.
Vaishali Pharma Board Meeting Date
Vaishali Pharma has scheduled an audit committee meeting for 5 November 2026. Proposed agenda includes a fund raise via preferential issue and an increase in authorised capital.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.